Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, KS, 66160, USA.
Food Chem Toxicol. 2020 Feb;136:111075. doi: 10.1016/j.fct.2019.111075. Epub 2019 Dec 23.
Alcohol-related liver disease (ALD) and drug-induced liver injury (DILI) are common causes of severe liver disease, and successful treatments are lacking. Autophagy plays a protective role in both ALD and DILI by selectively removing damaged mitochondria (mitophagy), lipid droplets (lipophagy), protein aggregates and adducts in hepatocytes. Autophagy also protects against ALD by degrading interferon regulatory factor 1 (IRF1) and damaged mitochondria in hepatic macrophages. Specifically, we will discuss selective autophagy for removal of damaged mitochondria and lipid droplets in hepatocytes and autophagy-mediated degradation of IRF1 in hepatic macrophages as protective mechanisms against alcohol-induced liver injury and steatosis. In addition, selective autophagy for removal of damaged mitochondria and protein adducts for protection against DILI is discussed in this review. Development of new therapeutics for ALD and DILI is greatly needed, and selective autophagy pathways may provide promising targets. Drug and alcohol effects on autophagy regulation as well as protective mechanisms of autophagy against DILI and ALD are highlighted in this review.
酒精性肝病 (ALD) 和药物性肝损伤 (DILI) 是严重肝病的常见病因,目前缺乏有效的治疗方法。自噬在 ALD 和 DILI 中都发挥着保护作用,通过选择性地清除受损的线粒体 (线粒体自噬)、脂滴 (脂滴自噬)、肝细胞中的蛋白质聚集体和加合物。自噬还通过降解干扰素调节因子 1 (IRF1) 和肝巨噬细胞中的受损线粒体来防止 ALD。具体来说,我们将讨论肝细胞中受损线粒体和脂滴的选择性自噬以及肝巨噬细胞中 IRF1 的自噬介导降解,作为对抗酒精性肝损伤和脂肪变性的保护机制。此外,本文还讨论了选择性自噬用于清除受损线粒体和蛋白质加合物以防止 DILI。非常需要开发治疗 ALD 和 DILI 的新疗法,选择性自噬途径可能提供有前途的靶点。本文重点介绍了药物和酒精对自噬调节的影响以及自噬对 DILI 和 ALD 的保护机制。